{
  "id": 2005800,
  "title": "HRT Financial LP sells $109,266 of Profusa stock",
  "url": "https://urgent.news/2026/08/19/hrt-financial-lp-sells-109-266-of-profusa-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-19T19:46:20.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/hrt-financial-lp-sells-109266-of-profusa-stock-93CH-4868082"
  },
  "original_language": "en",
  "account": "HRT Financial LP, a 10% owner of Profusa Inc., divested 18,395 shares of the company's stock on August 17, 2026. The transaction took place at a price of $5.94 per share, resulting in a total sale value of $109,266. This sale occurred amidst the stock's extreme volatility, with shares trading at $12.35 and experiencing a 612% return over the past week. HRT Financial LP is no longer a shareholder in Profusa Inc., as the complete divestment leaves them with zero shares of the company's common stock. The financial health of Profusa Inc. is currently classified as WEAK by InvestingPro, indicating significant financial challenges for the company. Despite the recent sale, Profusa Inc. continues to navigate regulatory matters, including the approval of proposals for the acquisition of the PanOmics multi-omics diagnostics platform, an amendment to its equity incentive plan, and a 1-for-25 reverse stock split.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}